Condition: Cataract and IOL Surgery · Sponsor: Assistance Publique - Hôpitaux de Paris
Retrospective, comparative, interventional, randomized, single-center study, contralateral (the patient's 2 eyes will be implanted: 1 CPO and the other APO) Patients presenting for cataract surgery with a request for presbyopia correction and managed as part of routine clinical practice. The main aim of the study is to demonstrate that contrast sensitivity is better with the Clareon PanOptix (CPO) intraocular lens (IOL) compared with the AcrySof PanOptix (APO) IOL 3 months after implantation.
This description comes directly from the study's public registry record.
Dominique MONNET, MD, PhD · 01 58 41 22 01 · dominique.monnet@aphp.fr
Valérie PLENCE, MSc · valerie.plence-fauroux@aphp.fr
Always discuss trial participation with your own doctor first.
| Assistance Publique - Hôpitaux de Paris, Ophtalomopôle - Hôpital COCHIN | Paris, Île-de-France Region, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07158177